151 related articles for article (PubMed ID: 23672612)
1. Melanoma inhibitory activity promotes melanoma development through activation of YBX1.
Schmid R; Meyer K; Spang R; Schittek B; Bosserhoff AK
Pigment Cell Melanoma Res; 2013 Sep; 26(5):685-96. PubMed ID: 23672612
[TBL] [Abstract][Full Text] [Related]
2. YBX1 is a modulator of MIA/CD-RAP-dependent chondrogenesis.
Schmid R; Meyer K; Spang R; Schittek B; Bosserhoff AK
PLoS One; 2013; 8(12):e82166. PubMed ID: 24349210
[TBL] [Abstract][Full Text] [Related]
3. p54nrb is a new regulator of progression of malignant melanoma.
Schiffner S; Zimara N; Schmid R; Bosserhoff AK
Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression.
Poser I; Golob M; Weidner M; Buettner R; Bosserhoff AK
Cancer Res; 2002 Oct; 62(20):5962-6. PubMed ID: 12384563
[TBL] [Abstract][Full Text] [Related]
5. Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration.
Winklmeier A; Contreras-Shannon V; Arndt S; Melle C; Bosserhoff AK
Cancer Sci; 2009 Feb; 100(2):261-8. PubMed ID: 19200257
[TBL] [Abstract][Full Text] [Related]
6. p54(nrb)/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A.
Zhu Z; Zhao X; Zhao L; Yang H; Liu L; Li J; Wu J; Yang F; Huang G; Liu J
Oncogene; 2016 Mar; 35(11):1399-410. PubMed ID: 26148231
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a transcription factor binding site, specifically activating MIA transcription in melanoma.
Golob M; Buettner R; Bosserhoff AK
J Invest Dermatol; 2000 Jul; 115(1):42-7. PubMed ID: 10886506
[TBL] [Abstract][Full Text] [Related]
8. p54nrb/NONO regulates cyclic AMP-dependent glucocorticoid production by modulating phosphodiesterase mRNA splicing and degradation.
Lu JY; Sewer MB
Mol Cell Biol; 2015 Apr; 35(7):1223-37. PubMed ID: 25605330
[TBL] [Abstract][Full Text] [Related]
9. Expression, function and clinical relevance of MIA (melanoma inhibitory activity).
Bosserhoff AK; Buettner R
Histol Histopathol; 2002 Jan; 17(1):289-300. PubMed ID: 11813878
[TBL] [Abstract][Full Text] [Related]
10. Expression of melanoma inhibitory activity in melanoma and nonmelanoma tissue specimens.
Perez RP; Zhang P; Bosserhoff AK; Buettner R; Abu-Hadid M
Hum Pathol; 2000 Nov; 31(11):1381-8. PubMed ID: 11112213
[TBL] [Abstract][Full Text] [Related]
11. Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo.
Bosserhoff AK; Echtenacher B; Hein R; Buettner R
Melanoma Res; 2001 Aug; 11(4):417-21. PubMed ID: 11479431
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype.
Poser I; Golob M; Buettner R; Bosserhoff AK
Mol Cell Biol; 2003 Apr; 23(8):2991-8. PubMed ID: 12665595
[TBL] [Abstract][Full Text] [Related]
13. Functional role of MIA in melanocytes and early development of melanoma.
Poser I; Tatzel J; Kuphal S; Bosserhoff AK
Oncogene; 2004 Aug; 23(36):6115-24. PubMed ID: 15208686
[TBL] [Abstract][Full Text] [Related]
14. Detailed analysis of MIA protein by mutagenesis.
Stoll R; Lodermeyer S; Bosserhoff AK
Biol Chem; 2006 Dec; 387(12):1601-6. PubMed ID: 17132106
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene.
Kobi D; Steunou AL; Dembélé D; Legras S; Larue L; Nieto L; Davidson I
Pigment Cell Melanoma Res; 2010 Jun; 23(3):404-18. PubMed ID: 20337985
[TBL] [Abstract][Full Text] [Related]
16. Mouse CD-RAP/MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcoma.
Bosserhoff AK; Kondo S; Moser M; Dietz UH; Copeland NG; Gilbert DJ; Jenkins NA; Buettner R; Sandell LJ
Dev Dyn; 1997 Apr; 208(4):516-25. PubMed ID: 9097023
[TBL] [Abstract][Full Text] [Related]
17. Melanoma inhibitory activity (MIA): an important molecule in melanoma development and progression.
Bosserhoff AK
Pigment Cell Res; 2005 Dec; 18(6):411-6. PubMed ID: 16280006
[TBL] [Abstract][Full Text] [Related]
18. P54/nrb prompts rheumatoid arthritis progression mainly by transcriptionally activating NF-κB signaling.
Li Q; Guo H; Li H; Zhu Q; Liu Y
Pharmazie; 2017 May; 72(5):260-264. PubMed ID: 29441870
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of ASK/Dbf4 in cutaneous melanoma is dependent on E2F1.
Nambiar S; Mirmohammadsadegh A; Hassan M; Hegemann JH; Hengge UR
Exp Dermatol; 2008 Dec; 17(12):986-91. PubMed ID: 18503552
[TBL] [Abstract][Full Text] [Related]
20. LncRNA BASP1-AS1 interacts with YBX1 to regulate Notch transcription and drives the malignancy of melanoma.
Li Y; Gao Y; Niu X; Tang M; Li J; Song B; Guan X
Cancer Sci; 2021 Nov; 112(11):4526-4542. PubMed ID: 34533860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
